LSE : 0HNC.L

BioMarin Pharmaceutical Inc. — Stock Grades

$59.31 USD

$1.27 (2.19%)

Volume
181
Average Volume
5.97K
Market Capitalization
$10.56B
P/E Ratio
42.38
Dividend Yield
0.00%
Price Target
Year High
$99.65
Year Low
$58.89
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$5.81
0HNC.L Stock Grades
Date Grading Company Previous Grade New Grade Action
2026-07-16 Citigroup Buy Buy Maintain
2026-07-07 RBC Capital Sector Perform Sector Perform Maintain
2026-05-22 Canaccord Genuity Buy Buy Maintain
2026-05-19 B of A Securities Buy Buy Maintain
2026-05-18 HC Wainwright & Co. Neutral Neutral Maintain
2026-05-07 Canaccord Genuity Buy Buy Maintain
2026-05-05 Evercore ISI Group Outperform Outperform Maintain
2026-05-05 Morgan Stanley Overweight Overweight Maintain
2026-05-05 Bernstein Outperform Outperform Maintain
2026-05-05 HC Wainwright & Co. Neutral Neutral Maintain
2026-05-05 RBC Capital Sector Perform Sector Perform Maintain
2026-03-11 B of A Securities Buy Buy Maintain
2026-03-04 Barclays Overweight Overweight Maintain
2026-03-02 HC Wainwright & Co. Neutral Neutral Maintain
2026-03-02 Freedom Broker Buy Buy Maintain
2026-02-26 Canaccord Genuity Buy Buy Maintain
2026-02-25 HC Wainwright & Co. Neutral Neutral Maintain
2026-02-25 Bernstein Outperform Outperform Maintain
2026-02-25 Guggenheim Buy Buy Maintain
2026-02-24 Oppenheimer Outperform Outperform Maintain
2026-02-18 Wells Fargo Overweight Overweight Maintain
2026-02-06 Piper Sandler Overweight Overweight Maintain
2026-01-20 Canaccord Genuity Hold Buy Upgrade